Growth Metrics

Cme (CME) Depreciation & Amortization (IS) (2016 - 2019)

Cme (CME) has disclosed Depreciation & Amortization (IS) for 11 consecutive years, with $38.0 million as the latest value for Q4 2019.

  • On a quarterly basis, Depreciation & Amortization (IS) rose 15.5% to $38.0 million in Q4 2019 year-over-year; TTM through Dec 2019 was $158.6 million, a 33.61% increase, with the full-year FY2025 number at $107.5 million, down 6.6% from a year prior.
  • Depreciation & Amortization (IS) was $38.0 million for Q4 2019 at Cme, down from $41.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $46.3 million in Q2 2019 to a low of $26.9 million in Q3 2017.
  • A 5-year average of $32.3 million and a median of $31.5 million in 2015 define the central range for Depreciation & Amortization (IS).
  • Peak YoY movement for Depreciation & Amortization (IS): fell 17.21% in 2017, then surged 68.36% in 2019.
  • Cme's Depreciation & Amortization (IS) stood at $28.1 million in 2015, then grew by 19.93% to $33.7 million in 2016, then fell by 17.21% to $27.9 million in 2017, then rose by 17.92% to $32.9 million in 2018, then grew by 15.5% to $38.0 million in 2019.
  • Per Business Quant, the three most recent readings for CME's Depreciation & Amortization (IS) are $38.0 million (Q4 2019), $41.4 million (Q3 2019), and $46.3 million (Q2 2019).